Fig. 2From: Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s diseaseSerum and CSF profiles differ between PD and HC subjects and show distinct diurnal fluctuations. The top diagram summarizes significant results. When sampled across a 26-h period, protein levels of CSF TNF (a), and serum IL-6 (b) fluctuate significantly across the day (F (10,154) = 4.66; p < 0.00001, and F (10,160) = 3.12; p < 0.00001, respectively). CSF IL-8 (c), α-synuclein (d), Aβ40 (e), and Aβ42 (f) are decreased in PD as compared to age-matched HC (F (1,16) = 5.08; p = 0.04, F (1,16) = 8.35 p = 0.01, F (1,16) = 14.69; p = 0.001, and F (1,16) = 4.61; p = 0.05, respectively), and vary across the day (F (10,154) = 2.23; p = 0.01, F (10,160) = 3.30; p < 0.001, F (10,160) = 4.11; p < 0.0001, and F (10,160) = 2.15; p = 0.02, respectively). Serum TNF (g) and serum IFNγ (i) are decreased in PD subjects compared to HC subjects (F (1,16) = 208.58; p < 0.00001 and F (1,16) = 8.49; p = 0.009, respectively), and serum NGAL (h) is increased in PD compared to HC subjects (F (1,16) = 25.98; p < 0.00001). When measured at baseline (time 0 = 5:30 AM), serum TNF (g) was significantly lower in PD subjects as compared with HC subjects (U (83, 88) = 10; p = 0.014), and serum NGAL (h) was significantly higher in PD subjects as compared with HC subjects (U (31, 140) = 10; p = 0.014). There were no differences between PD and HC in any other analyte (see Table 2 for all data). *Indicates significant change in time, and + indicates significant difference between PD and HC. *** and +++ indicate p < 0.0001, ** and ++ indicate p < 0.01, * and + indicate p ≤ 0.05, and ^ indicates a significant difference between PD and HC at time 0; p < 0.05. Superscript numbers indicate the sampling hour where significant changes occurBack to article page